Research
Hormonal
Obstructive sleep apnea (OSA) independently causes insulin resistance, hypertension, and visceral obesity, contributing directly to the metabolic syndrome.
If you have symptoms of sleep apnea (loud snoring, daytime fatigue, witnessed breathing pauses), get tested. Treating OSA with CPAP can improve blood pressure, lipid profiles, and insulin sensitivity, reducing your risk of heart disease and diabetes, independent of weight loss.
GoodSupportsHIGH confidence
This review discusses the evidence that sleep disturbances (obstructive sleep apnoea, sleep deprivation and shift work) may independently lead to the development of both insulin resistance and individual clinical components of the metabolic syndrome.
Why this rating
Strong observational and some experimental data, but the paper notes causality is not fully proven and studies are often confounded.
Source
Sleep and the metabolic syndrome
Robert Wołk et al. · Experimental Physiology · 2006
DOI 10.1113/expphysiol.2006.033787
narrative_reviewCited 184×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →